Literature DB >> 4527793

Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia.

F Sackmann Muriel, S Pavlovsky, J A Peñalver, G Hidalgo, A Cebrian Bonesana, M Eppinger-Helft, G H De Macchi, A Pavlovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4527793     DOI： 10.1002/1097-0142(197408)34:2<418::aid-cncr2820340227>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

Review 1.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Combination chemotherapy for acute lymphoblastic leukaemia in adults.

Authors:  T A Lister; J M Whitehouse; M E Beard; R L Brearley; P F Wrigley; R T Oliver; J E Freeman; R K Woodruff; J S Malpas; A M Paxton; D Crowther
Journal:  Br Med J       Date:  1978-01-28

3.  Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.

Authors:  G Garay; J Milone; E Dibar; S Pavlovsky; R Kvicala; F Sackmann Muriel; D Montres Varela; M Eppinger-Helft
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.

Authors:  Sue Richards; Ching-Hon Pui; Paul Gayon
Journal:  Pediatr Blood Cancer       Date:  2012-06-12       Impact factor: 3.167

5.  Early central nervous system involvement in adults with acute non-myelogenous leukaemia.

Authors:  T A Lister; J M Whitehouse; M E Beard; A Paxton; R L Brearley; L Brown; P F Wrigley; D Crowther
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.